We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$156B
AUM Growth
-$21.1B
(-12%)
Cap. Flow
-$19.2B
Cap. Flow
% of AUM
-12.28%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
2,506
New
88
Increased
1,137
Reduced
1,110
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$697M |
| 2 |
ASML
ASML
|
+$575M |
| 3 |
CRH
CRH
|
+$473M |
| 4 |
ServiceNow
NOW
|
+$442M |
| 5 |
Meta Platforms (Facebook)
META
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.65B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$977M |
| 4 |
Apple
AAPL
|
+$923M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$843M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Financials | 11.5% |
| 3 | Industrials | 11.05% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Healthcare | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Rocket Pharmaceuticals
RCKT
$348M
| $41.4K | ﹤0.01% |
11,558
+89
| +0.8% | +$354 |
|
2302
Pacific Biosciences
PACB
$422M
| $40.7K | ﹤0.01% |
30,843
-341
| -1% | -$610 |
|
2303
American Battery Technology Co
ABAT
$301M
| $40.6K | ﹤0.01% |
14,555
+98
| +0.7% | +$378 |
|
2304
Clean Energy Fuels
CLNE
$447M
| $39.9K | ﹤0.01% |
16,084
-157
| -1% | -$366 |
|
2305
Standard BioTools
LAB
$326M
| $38.8K | ﹤0.01% |
42,175
-267
| -0.6% | -$323 |
|
2306
Community Health Systems
CYH
$385M
| $38.6K | ﹤0.01% |
13,133
+87
| +0.7% | +$282 |
|
|
ELME
2307
Elme Communities
ELME
$132M
| $38.6K | ﹤0.01% |
19,183
-4,050
| -17% | -$13.3K |
|
2308
W&T Offshore
WTI
$545M
| $38.4K | ﹤0.01% |
11,248
-67
| -0.6% | -$166 |
|
2309
Cerus
CERS
$587M
| $38.1K | ﹤0.01% |
20,953
-95
| -0.5% | -$207 |
|
|
NXDR
2310
Nextdoor Holdings
NXDR
$835M
| $38.1K | ﹤0.01% |
27,201
+2,070
| +8% | +$3.6K |
|
|
OPTU
2311
Optimum Communications Inc
OPTU
$316M
| $38K | ﹤0.01% |
29,234
+978
| +3% | +$1.54K |
|
2312
iHeartMedia
IHRT
$535M
| $37.8K | ﹤0.01% |
12,948
-372
| -3% | -$1.23K |
|
2313
Prime Medicine
PRME
$533M
| $37.6K | ﹤0.01% |
10,817
+16
| +0.1% | +$61 |
|
2314
ThredUp
TDUP
$736M
| $35.9K | ﹤0.01% |
10,938
+161
| +1% | +$747 |
|
2315
Lexicon Pharmaceuticals
LXRX
$1.02B
| $35.4K | ﹤0.01% |
22,679
+1,488
| +7% | +$2.16K |
|
2316
Beyond Meat
BYND
$288M
| $35.3K | ﹤0.01% |
50,282
+314
| +0.6% | +$251 |
|
2317
Gossamer Bio
GOSS
$66.5M
| $35.2K | ﹤0.01% |
107,141
+1,587
| +2% | +$2.49K |
|
2318
Microvast
MVST
$267M
| $35K | ﹤0.01% |
23,323
-596,076
| -96% | -$1.44M |
|
2319
Blend Labs
BLND
$409M
| $35K | ﹤0.01% |
20,568
-1,460
| -7% | -$3.12K |
|
2320
Digital Turbine
APPS
$1.02B
| $34.9K | ﹤0.01% |
12,135
+867
| +8% | +$3.72K |
|
2321
Krispy Kreme
DNUT
$543M
| $34.9K | ﹤0.01% |
10,299
+37
| +0.4% | +$128 |
|
2322
Maravai LifeSciences
MRVI
$997M
| $33.8K | ﹤0.01% |
11,927
-247
| -2% | -$837 |
|
2323
Invivyd
IVVD
$180M
| $33.4K | ﹤0.01% |
25,703
-273
| -1% | -$501 |
|
2324
Anavex Life Sciences
AVXL
$222M
| $31.5K | ﹤0.01% |
+10,275
| New | +$44.5K |
|
2325
Vista Gold
VGZ
$253M
| $31.4K | ﹤0.01% |
15,996
+1,869
| +13% | +$4.42K |
|
Similar funds
Victory Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Victory Capital Management held 2,506 positions worth $156B, down 12% from $177B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Victory Capital Management withdrew a net $19.2B in Q1 2026, closing 97 positions and reducing 1,110 holdings. Its most notable exit was iShares MSCI Emerging Markets ex China ETF, an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Victory Capital Management opened a new position in Amrize Ltd worth $218M.
- Victory Capital Management's largest Q1 2026 buy was Amrize Ltd: 3,886,958 shares worth $218M.
- Victory Capital Management added most to Accenture in Q1 2026, an estimated $697M increase.
- Victory Capital Management's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.65B.
- Victory Capital Management fully exited iShares MSCI Emerging Markets ex China ETF in Q1 2026, selling an estimated $136M.
- Victory Capital Management's ten largest holdings make up 18% of its $156B portfolio in Q1 2026.
- Victory Capital Management opened 88 new positions and closed 97 in Q1 2026.
- Victory Capital Management's portfolio value fell 12% quarter-over-quarter to $156B.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.